E
Elisa Merelli
Researcher at University of Modena and Reggio Emilia
Publications - 45
Citations - 2095
Elisa Merelli is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Multiple sclerosis & Virus. The author has an hindex of 20, co-authored 45 publications receiving 1973 citations. Previous affiliations of Elisa Merelli include Academy for Urban School Leadership & University of Pisa.
Papers
More filters
Journal ArticleDOI
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
Angelo Ghezzi,Roberto Bergamaschi,Vittorio Martinelli,Maria Trojano,M. Rosaria Tola,Elisa Merelli,Luigi Mancardi,Paolo Gallo,Massimo Filippi,Mauro Zaffaroni,Giancarlo Comi +10 more
TL;DR: Compared with MS, DNO patients have a higher age at onset, females are more frequently affected, the course is more severe and DNO has a poor prognosis in most cases.
Journal ArticleDOI
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
Riccardo Saccardi,Tomas Kozak,Chiara Bocelli-Tyndall,A Fassas,Aristidis Kazis,Eva Havrdova,Enric Carreras,Albert Saiz,Bob Löwenberg,P Aw te Boekhorst,Francesca Gualandi,Harry Openshaw,G Longo,F Pagliai,Luca Massacesi,E Deconink,J Ouyang,F Jz Nagore,Juan Besalduch,I. Lisukov,A Bonini,Elisa Merelli,Shimon Slavin,Alois Gratwohl,Jakob Passweg,Alan Tyndall,Andreas J. Steck,M Andolina,Marco Capobianco,J Ld Martin,Alessandra Lugaresi,Giuseppe Meucci,Ricardo Saez,Richard E. Clark,Mario Fernandez,L. Fouillard,B. Herstenstein,Vladimir Koza,Eleonora Cocco,H Baurmann,G. L. Mancardi +40 more
TL;DR: HSCT was shown as a promising procedure to slow down progression in a subset of patients affected by severe, progressive MS; the safety and feasibility of the procedure can be significantly improved by appropriate patient selection and choice of transplant regimen.
Journal ArticleDOI
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Giovanni Luigi Mancardi,Maria Pia Sormani,Francesca Gualandi,Albert Saiz,Eric Carreras,Elisa Merelli,Amedea Donelli,Alessandra Lugaresi,Paolo Bartolomeo,M. Rottoli,Alessandro Rambaldi,Maria Pia Amato,Luca Massacesi,Massimo Di Gioia,Luisa Vuolo,Daniela Currò,Luca Roccatagliata,Massimo Filippi,Umberto Aguglia,Pasquale Iacopino,Dominique Farge,Riccardo Saccardi,Marrow Transplantation,Marrow Transplantation Ebmt +23 more
TL;DR: Intense immunosuppression followed by AHSCT is significantly superior to MTX in reducing MRI activity in severe cases of MS, and these results strongly support further phase III studies with primary clinical endpoints.
Journal ArticleDOI
Three cases of human herpesvirus‐6 latent infection: Integration of viral genome in peripheral blood mononuclear cell DNA
Mario Luppi,Roberto Marasca,P. Barozzi,Sergio Ferrari,Luca Ceccherini-Nelli,Giovanna Batoni,Elisa Merelli,Giuseppe Torelli +7 more
TL;DR: The study showed the presence of intact viral genome, of the expected length of 170 kb, persisting as free extrachromosomal element in the HSB‐2 cells but not in patients' peripheral blood mononuclear cells, indicating that the viral sequences are linked to high molecular weight cellular DNA.
Journal ArticleDOI
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo
Giuseppe Torelli,Patrizia Barozzi,Roberto Marasca,Paola Cocconcelli,Elisa Merelli,Luca Ceccherini-Nelli,Sergio Ferrari,Mario Luppi +7 more
TL;DR: A further study of the same patients with chromo some fluorescence in situ hybridization showed the presence of a specific hybridization site, located at the telomeric extremity of the short arm of chromosome 17 (17p13), suggesting that this location is at least a preferred site of an infrequent, but biologically important, integration phenomenon.